All In MedTech

FDA Clearance Tracker · P050053-S017

INFUSE BONE GRAFT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 26, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P050053-S017
Device name
INFUSE BONE GRAFT
Applicant location
Memphis, TN
Received
Sep 1, 2010
Decided
Jan 26, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P050053

Device type

Device class
Class III
Regulation
21 CFR 872.3930

Every decision under product code NPZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED IN ANÞASCO, PUERTO RICO TO PERFORM POST-ALKALI TREATMENT STEPS FOR THE ABSORBABLE COLLAGEN SPONGE (ACS).

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.